Vimarsana
Biggest News Aggregation in the World

Precision Olfactory Delivery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Olfactory Delivery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Olfactory Delivery Today - Breaking & Trending Today

Global Mucosal Atomization Devices Market Report 2023: Gas-propelled Devices are Expected to be Fastest Growing Segment - Vimarsana News

Global Mucosal Atomization Devices Market Report 2023: Gas-propelled Devices are Expected to be Fastest Growing Segment

/PRNewswire/ -- The "Mucosal Atomization Devices Market - Growth, Trends, and Forecasts (2023 - 2028)" report has been added to ResearchAndMarkets.com's...

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

Trudhesa® Achieved nTRx of Over 18.5K in Q1 2023; Increase of 112% vs. Q1 2022 Trudhesa Net Product Revenue in Q1 2023 Increased 149% vs. Q1 2022 to $4.4 Million Impel to Host Investor... | May 12, 2023

Impel Pharmaceuticals Presents New Data at AAN 2023 - Vimarsana News

Impel Pharmaceuticals Presents New Data at AAN 2023

New Analysis Indicates No Drug-Drug Interactions (DDIs) of Clinical Concern are Predicted When Recommended Doses of Trudhesa and Gepants are...

At Eighteen Months Post-Launch, Impel's Trudhesa Has Struggled to Keep Up with Pfizer's Nurtec ODT and AbbVie's Ubrelvy, According to Spherix Global Insights - Vimarsana News

At Eighteen Months Post-Launch, Impel's Trudhesa Has Struggled to Keep Up with Pfizer's Nurtec ODT and AbbVie's Ubrelvy, According to Spherix Global Insights

/PRNewswire/ -- Spherix Global Insights recently released data from their Launch Dynamix™: Trudhesa in Acute Treatment of Migraine (US) deep dive study...

Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting - Vimarsana News

Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting

Highlights Include Multiple Presentations Addressing Safety and Efficacy of TrudhesaSEATTLE, April 11, 2023 -- Impel Pharmaceuticals , a commercial-stage pharmaceutical company developing... | April 11, 2023